Physician profile
Alka V Sachdeva
NPI 1265441950
$3,949.70
in general payments reported to CMS, 2019-2025
28 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $76.19 · 2021: $351 · 2022: $814 · 2023: $826 · 2024: $793 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,147.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $966.80 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $659.45 | 2022-2025 | Freestyle Libre 3, Octrode, Proclaim |
| Lilly USA, LLC | $405.34 | 2019-2025 | Mounjaro, Zepbound, Lyumjev |
| Abbvie INC. | $253.68 | 2021-2024 | Vraylar |
| Amgen INC. | $248.91 | 2019-2025 | Evenity, Repatha, Prolia |
| Glaxosmithkline, LLC. | $238.13 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $209.81 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $154.83 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.58 | 2021-2024 | Jardiance |
| Exact Sciences Corporation | $102.82 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $75.99 | 2019-2023 | Belsomra, Verquvo |
| Astellas Pharma US INC | $73.45 | 2023-2025 | Veozah |
| Radius Health, INC. | $48.99 | 2023-2024 | Tymlos |
| Lifescan, INC. | $45.72 | 2021-2022 | |
| Dexcom, INC. | $43.88 | 2023 | Dexcom G6 Transmitter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $42.79 | 2022-2023 | Unithroid |
| Eisai INC. | $30.86 | 2021 | |
| Medtronic, INC. | $29.01 | 2023 | Intellis Adaptivestim |
| Beta Bionics, INC. | $25.18 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Bayer Healthcare Pharmaceuticals INC. | $24.01 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $23.83 | 2024 | Bylvay |
| Ibsa Pharma INC. | $22.28 | 2024 | Licart, Tirosint |
| Sumitomo Pharma America, INC. | $21.61 | 2024 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $17.17 | 2021 | |
| Currax Pharmaceuticals LLC | $17.07 | 2025 | Contrave |
| Novartis Pharmaceuticals Corporation | $15.58 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.10 | 2021 | |
| Medtronic USA, INC. | $14.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alka Sachdeva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.